UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes

Diabetes Care

Volumn 25, Issue 5, 2002, Pages 894-899

  Adler, Amanda I ^a,d   Stevens, Richard J ^a   Neil, Andrew ^b   Stratton, Irene M ^a   Boulton, Andrew J M ^c   Holman, Rury R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RETINOPATHY; RISK FACTOR; SENSORY NEUROPATHY; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; FEMALE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICAL MODEL; UNITED KINGDOM;

ADULT; AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036584224     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.5.894     Document Type: Article

References (37)

1. MacGregor AS, Price JF, Hau CM, Lee AJ, Carson MN, Fowkes FG: Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease: the Edinburgh Artery Study. Diabetes Care 22:453-458, 1999
2. Murabito J, D'Agostino R, Silbershatz H, Wilson P: Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 96:44-49, 1997
3. Bird CE, Criqui MH, Fronek A, Denenberg JO, Klauber MR, Langer RD: Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4:15-21, 1999
4. Boyko E, Ahroni JH, Smith DG, Davignon D: Increased mortality associated with diabetic foot ulcer. Diabet Med 13:967-972 1996
5. Barzilay J, Kronmal R, Bittner V, Eaker E, Evans C, Foster E: Coronary artery disease in diabetic patients with lower-extremity arterial disease: disease characteristics and survival. Diabetes Care 20:1381-1387, 1997
6. Adler A, Boyko E, Ahroni J, Smith D: Lower extremity amputation in diabetes mellitus: the independent effects of peripheral vascular disease, sensory neuropathy and foot ulcers. Diabetes Care 22:1029-1035, 1999
7. Currie CJ, Morgan CL, Peters JR: The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 21:42-48, 1998
8. Beks PJ, Mackay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 38:86-96, 1995
9. Walters D, Gatling W, Mullee M, Hill R: The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 9:710-715, 1992
10. Janka H, Becker A, Muller R: Arterielle verschlusskrankheit der extremitaten bei diabetikem. Diabetes Stoffwechsel 2:68-72, 1993
11. UKPDS Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
12. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, John Wiley & Sons, 1989
13. Orchard T, Dorman J, Maser R, Becker D, Drash A, Ellis D, LaPorte R, Kuller L: Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
14. Feigelson HS, Criqui MH, Fronek A, Langer RD, Molgaard CA: Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol 140:526-534, 1994
15. Boyko EJ, Ahroni JH, Davignon D, Stensel V, Prigeon RL, Smith DG: Diagnostic utility of the history and physical examination for peripheral vascular disease among patients with diabetes mellitus. J Clin Epidemiol 50:659-668, 1997
16. Emanuele M, Buchanan B, Abraira C: Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care 4:289-292, 1981
17. Gilbey SG, Walters H, Edmonds ME, Archer AG, Watkins PJ, Parsons V, Grenfell A: Vascular calcification, autonomic neuropathy, and peripheral blood flow in patients with diabetic nephropathy. Diabet Med 6:37-42, 1989
18. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
19. Uusitupa M, Niskanen L, Siitonen O, Voutilainen E, Pyorala K: 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 82:27-36, 1990
20. Pirart J: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168-188, 1978
21. Kreines K, Johnson E, Albrink M, Knatterud G, Levin M, Lewitan A, Newberry W, Rose F: The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 8:235-243, 1985
22. Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C, Hadden D, Holman R, for the UKPDS Group: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ 321:405-411, 2000
23. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ: Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159-169, 2000
24. Hoogeveen EK, Kostense PJ, Jakobs C, Rauwerda JA, Dekker JM, Nijpels G, Bouter LM, Heine RJ, Stehouwer CD: Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: the Hoorn Study. J Intern Med 247:442-448, 2000
25. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926-931, 1999
26. Ceriello A, Quatraro A, Giugliano D: New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 9:297-299, 1992
27. Bowie A, Owens D, Collins P, Johnson A, Tomkin G: Glycosylated low density lipoprotein is more sensitive to oxidation. Implications for the diabetic patient? Atherosclerosis 102:63-67, 1993
28. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
29. Priollet P: Arterial disease of the lower limbs in the diabetic. In Vascular Complications of Diabetes. Turner RC, Ed. Paris, Editions Pradel, 1994, p. 145-150
30. Blumenthal HT, Berns AW, Goldenberg S, Lowenstein PW: Etiologic considerations in peripheral vascular diseases of the lower extremity with special reference to diabetes mellitus. Circulation 33:98-106, 1966
31. Abbott RD, Brand FN, Kannel WB: Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study. Am J Med 88:376-381, 1990
32. Tibell B: Peripheral arterial insufficiency; an epidemiological study of 2,243 hospital admissions caused by arteriosclerosis obliterans, diabetes mellitus, thrombangitis obliterans and arterial embolism. Acta Orthop Scand Suppl 139:1-54, 1971
33. Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB, Cowan LD, Gray RS, Welly TK, Go OT, Howard WJ: LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart Study. Arterioscler Thromb Vasc Biol 20:830-835, 2000
34. Elias AN, Domurat E: Erythrocyte sedimentation rate in diabetic patients: relationship to glycosylated hemoglobin and serum proteins. J Med 20:297-296, 1989
35. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283:221-228, 2000
36. Schmidt AM, Crandall J, Jori O, Cao R, Lakatta E: Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol 92:747-750, 1996
37. Wollesen F, Dahlen G, Berglund L, Berne C: Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Diabetes Care 22:93-98, 1999